← Back

$ Value

$0

Shares

155,100

Price

$0

Filed

Feb 24

Insider

Name

McMinn Rachel

Title

Chief Executive Officer

CIK

0001606302

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

155,100

Footnotes

Consist of 25,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date. | Includes (a) 23,900 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (b) 25,900 restricted stock units granted on February 20, 2029, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029. Due to an administrative error, the amount reported in Column 5 on the Reporting Person's Form 4 filed on March 28, 2025 was understated by the 47,500 shares reported as purchased by the Reporting Person on the Reporting Person's Form 4 filed on November 25, 2024. This Form 4 reflects the correct amount of common stock beneficially owned by the Reporting Person. | This option represents the right to purchase 155,100 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.

Filing Info

Accession No.

0001606302-26-000002

Form Type

4

Issuer CIK

0001404644

McMinn Rachel's History

Date Ticker Type Value
2026-03-26 NGNE $74K
2026-02-20 NGNE A $0
2026-02-20 NGNE A $0

Other Insiders at NGNE (90d)

Insider Bought Sold Last
BAFFI ROBERT 2026-02-20
PALEKAR ROHAN 2026-02-20
Cvijic Christine Mikail
President and CFO
$260K 2026-03-26
McMinn Rachel
Chief Executive Officer
$74K 2026-03-26
Noonberg Sarah B. 2026-02-20
Freedland Cory S. 2026-02-20
Jordan Julie
Chief Medical Officer
$18K 2026-03-26
Cobb Stuart
Chief Scientific Officer
$141K 2026-03-13
Woods Keith 2026-02-20